H.R. 5882

Referred to Committee

GENE Therapy Payment Act

Introduced 2/12/2020•116th Congress•House

Congress.gov

Latest Action

Referred to the House Committee on Energy and Commerce.

2/12/2020 • House

Summary

Generating Effective and Novel Evidence for Therapy Payment Act or the GENE Therapy Payment Act

This bill allows state Medicaid programs to pay for certain gene therapy drugs through risk-sharing value-based payment agreements with drug manufacturers. The bill applies to covered outpatient drugs that provide potentially curative treatment for serious or life-threatening rare diseases or conditions after not more than three administrations.

Introduced in House • 2/12/2020

Enter your district to see how this bill affects your community

Topics & Subjects

Policy Area: Health

Administrative law and regulatory proceduresAppropriationsCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyGeneticsGovernment studies and investigationsHealth care costs and insuranceHome and outpatient careIntergovernmental relationsManufacturingMedicaidPrescription drugsState and local government operations